The popularity of Danish drugmaker Novo Nordisk has propelled its shares to a sky-high valuation, leaving little room for any disappointment with Europe’s most-valuable company.
Read More >>Weight-Loss Giant Novos Fat Valuation Leaves No Room For Error
